As previously communicated, the agreed price for the acquisition and the long-term partnership is €5.1 billion, with the closing expected mid-2025 and an anticipated impact on BNP Paribas Group's CET1 ...
YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing therapy for ATTR amyloidosis. The ...
越南河內2024年12月21日 /美通社/ -- 2024年12月20日,Viettel High Tech (VHT)與High Cloud Technologies ...
THE WOODLANDS, Texas, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it has received a complete response letter (CRL) from the U.S. Food and Drug ...
Onfolio acquires and manages a diversified portfolio of online businesses. Onfolio acquires business that meet its investment criteria, being that such businesses operate in sectors with long-term ...
WALNUT, CA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive ...
Copies of the prospectus supplement and the accompanying prospectus relating to this offering may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting Craft Capital ...
Immutable Holdings Inc. (NEO:HOLD) (“Immutable Holdings” or the “Corporation”), a publicly-traded blockchain holding company, is ...
To implement China's national strategy of regional integrated development, CPIC positioned the Greater Bay Area (GBA) as the "high ground of innovation" in 2021.
Company Limited ("CPIC Life (HK)") received the approval from the Hong Kong Insurance Authority to conduct long-term insurance business in Hong Kong, marking the official launch of the company. On the ...
Both a bar for AIA Carnival goers and a ticketed event venue, the line-up includes events by Jokerz x Takeout Comedy, Cassio, Benny Cee, Soho House, Reflex/Broadback, Lan Kwai Fong, Dead Poets, Call ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...